Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000507444 | SCV000605165 | likely benign | not specified | 2016-09-15 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727150 | SCV000706164 | uncertain significance | not provided | 2017-02-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001078524 | SCV001111571 | likely benign | Schneckenbecken dysplasia | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279293 | SCV002567013 | likely benign | Connective tissue disorder | 2022-05-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002524926 | SCV003609162 | uncertain significance | Inborn genetic diseases | 2021-06-18 | criteria provided, single submitter | clinical testing | The c.814G>A (p.A272T) alteration is located in exon 10 (coding exon 10) of the SLC35D1 gene. This alteration results from a G to A substitution at nucleotide position 814, causing the alanine (A) at amino acid position 272 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV000727150 | SCV003840652 | uncertain significance | not provided | 2023-03-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |